Press release
BIOTECON Diagnostics acquires LightCycler System Technology License from Roche Diagnostics
Mannheim, Potsdam, April, 2008 - BIOTECON Diagnostics, Potsdam and Roche Applied Science, a business unit of Roche Diagnostics have concluded a nonexclusive, worldwide licensing agreement for the development, production and marketing of PCR kits for the LightCycler instrument. The license includes rights for qualitative and quantitative detection and for the identification of harmful germs and genetic modifications in foodstuffs. The combination of Roche´s Light Cycler technology and BIOTECON´s verification procedures is especially attractive, because now it will be possible to provide tests which can detect very precisely traces of pathogens within one hour.“The LightCycler System Technology License represents a significant milestone for our company” states Kornelia Berghof-Jäger, CEO of BIOTECON Diagnostics. It enables us to strengthen our position as an innovative leader in the field of food molecular diagnostics and, together with the food industry, provide even greater food safety."
“The licensing of the LightCycler instrument technology to BIOTECON will further boost the development of this technology, and broaden its application range especially in the fields of food and cosmetics”, states Manfred Baier, Head of Roche Applied Science, a business area of Roche Diagnostics.
BIOTECON Diagnostics manages the worldwide marketing itself and through cooperation partners. The product will be distributed in Germany by Roche and Merck KGaA has undertaken the marketing of the complete test line in all other countries worldwide. The fast and reliable BIOTECON tests are based on Polymerase Chain Reaction (PCR): DNA traces are isolated from the food sample to be investigated with the LightCycler Instrument, which is able to simultaneously copy and detect them. This automation procedure results in considerably shorter analysis times, as well as simpler and more reliable tests which can be used by the food industry in various ways. The tests developed by BIOTECON Diagnostics implement the advantages of the Roche LightCycler instrument and are a safer and more cost efficient alternative to in-house development.
BIOTECON Diagnostics GmbH with it`s headquarter in Potsdam / Berlin (Germany) has been a competent partner for molecular biological and microbiological issues for more than ten years. The focus is the development, production and marketing of PCR-based rapid detection systems. BIOTECON Diagnostics offers solutions for the food and beverages industry as well as for pharmaceutical and cosmetics manufacturers.
Roche is a world leader amongst research-based companies in the health sector in the field of pharmaceuticals and diagnostics and has its headquarters in Basel, Switzerland. The innovative products and services from Roche cover the prevention, diagnosis and treatment of diseases and contribute to improved well-being and quality of life. Roche´s employees number around 64 000 and it sells its products in more than 170 countries. The diagnostics division has at its disposal a wide spectrum of innovative test products and services for doctors, patients, researchers, clinics and laboratories all over the world.
Contact:
Katrin Schwensow
Marketing
Phone +49 (0) 331 2300-245
Fax +49 (0) 331 2300-250
kschwensow@bc-diagnostics.com
BIOTECON Diagnostics
Hermannswerder 17
14473 Potsdam – Germany
Phone +49 (0) 331 2300-200
Fax +49 (0) 331 2300-299
E-mail bcd@bc-diagnostics.com
www.bc-diagnostics.com
BIOTECON Diagnostics GmbH with it`s headquarter in Potsdam / Berlin (Germany) has been a competent partner for molecular biological and microbiological issues for more than ten years. The focus is the development, production and marketing of PCR-based rapid detection systems. BIOTECON Diagnostics offers solutions for the food and beverages industry as well as for pharmaceutical and cosmetics manufacturers.
Roche is a world leader amongst research-based companies in the health sector in the field of pharmaceuticals and diagnostics and has its headquarters in Basel, Switzerland. The innovative products and services from Roche cover the prevention, diagnosis and treatment of diseases and contribute to improved well-being and quality of life. Roche´s employees number around 64 000 and it sells its products in more than 170 countries. The diagnostics division has at its disposal a wide spectrum of innovative test products and services for doctors, patients, researchers, clinics and laboratories all over the world.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BIOTECON Diagnostics acquires LightCycler System Technology License from Roche Diagnostics here
News-ID: 43272 • Views: …
More Releases from BIOTECON Diagnostics GmbH
BIOTECON Diagnostics GmbH and Biotest AG start wordlwide sales cooperation
In order to enhance the worldwide launch of its innovative Hygiene Screening System, BIOTECON Diagnostics GmbH Potsdam, Germany has started a global sales cooperation with the Business Unit Microbiology of BIOTEST AG in Eppelheim, Germany.
In September 2009 the dedicated sales force for the microbiological product range of Biotest AG will start to sell the system for rapid identification of microorganisms from hygiene monitoring samples. Corynebacterium, Staphylococcus, Micrococcus, Kocuria, and…
BIOTECON Diagnostics signs license agreement with Applera Corporation
Foster City, Potsdam, May, 2008 Applera and BIOTECON Diagnostics (BCD) announce a non-exclusive, worldwide license agreement relating to PCR technology for Food Testing Applications and Genetically-Modified Organism (GMO) Testing Applications: BIOTECON Diagnostics has acquired important rights with the PCR licence. It enables the company to strengthen its position as an innovative leader in the field of food molecular diagnostics and, together with the food industry, provide even greater food safety.…
More Releases for Roche
Germany Hepatitis C Testing Market Size, Trends, Growth, Opportunities (2024-203 …
The dental handpiece market was valued at USD 106.8 million in 2019 and is projected to grow from USD 80.1 million in 2020 to USD 121.4 million in 2027, recording a CAGR of 6.1% during the forecast period (2024-2032).
The Germany Hepatitis C Testing Market continues to grow as public health initiatives and advanced diagnostics play a pivotal role in managing the hepatitis C virus (HCV) epidemic. Germany's healthcare infrastructure is…
Atezolizumab Market Size, Growth Opportunities 2031 by Key Manufacturer- Genente …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Atezolizumab Market size was valued at USD 2.68 Billion in 2023 and is expected to reach USD 7.86 Billion by the end of 2031 with a CAGR of 16.6% During the Forecast Period 2023-2031.
The Atezolizumab Market presents significant opportunities driven by advancements in immuno-oncology, the growing prevalence of cancer, and the increasing demand for targeted cancer therapies. Atezolizumab is…
Biomarker Testing Market | Agilent Technologies, Roche, ,
The global biomarker testing market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the biomarker testing market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Tumor Immunotherapy Market 2023 Comprehensive Analysis - AstraZeneca, Pfizer Inc …
Global Tumor Immunotherapy Market 2023 is the fresh report by Fior Markets that is formulated with the exact understanding of customer requirements. The report covers comprehensive market analysis, evaluation of findings, as well as assumptions taken from a variety of sources. The research report offers an in-depth look at the service providers operating in the global Tumor Immunotherapy market. According to the analyst, the market is going through a large…
Tecentriq Market Analysis & Forecast 2021 - 2027|Roche, ,
Complete study of the global Tecentriq market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Tecentriq industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate…
PEGylated Protein Therapeutics Market Competitive Analysis | Amgen, AstraZeneca, …
PEGylated Protein Therapeutics Market analysis document helps identify the latest growths, market shares, and policies employed by the major market players. In addition, this market study affirms the leading players across the globe in the PEGylated Protein Therapeutics Market and their key marketing dispositions and advertising enterprise have been highlighted to offer a clear understanding of the market. The major topics of this document can be listed as; Overview of…